News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.
NCLH Shares Fall 4.1%, $0.74 Billion Trading Volume Ranks 188th in Market Turnover
101 finance·2026/03/03 23:21
Buy Broadcom Stock as Q1 Results Approach or Choose Nvidia Instead?
Finviz·2026/03/03 23:18
Rigel Pharmaceuticals (RIGL) Q4 Earnings Miss Estimates
Finviz·2026/03/03 23:18
Bitcoin jumps 5% before Trump Iran speech
Grafa·2026/03/03 23:12
Netflix - This chart is just wonderful!
TradingView·2026/03/03 23:09
Top Research Reports for Broadcom, AT&T & Vertex Pharmaceuticals
Finviz·2026/03/03 23:06
Rocket Lab's Stock Tumbles Despite 36% Revenue Surge Ranks 112th in $1.22B Trading Volume
101 finance·2026/03/03 23:03
Atlasbrary and Flux Partner to Boost Scalable Web3
BlockchainReporter·2026/03/03 23:00
Flash
20:36
U.S. federal banking regulators clarify capital treatment rules for tokenized securitiesThe U.S. federal banking regulators jointly issued a FAQ clarifying the capital treatment rules for tokenized securities. Tokenized securities refer to securities whose ownership is represented using distributed ledger technology. The FAQ states that eligible tokenized securities generally receive the same capital treatment under capital rules as their non-tokenized counterparts. Regulators emphasize that capital rules remain technologically neutral, and the technology used for issuing and trading securities usually does not affect capital treatment. Banks holding tokenized securities must follow risk management practices and comply with relevant laws and regulations.
20:02
Tevogen Bio Holdings (Tevogen) has recently taken a key step in its generic drug business strategy, signing a letter of intent to officially begin evaluating the potential acquisition of Apozeal Pharmaceuticals.This move marks Tevogen's accelerated expansion of its generic drug product line to strengthen its market competitiveness in the biopharmaceutical sector. Through this strategic assessment, Tevogen is expected to further integrate industry resources and increase its share in the global generic drug market.
20:01
Tevogen Bio Holdings Inc is currently actively evaluating other transaction opportunities and has strategically focused its priorities on businesses related to the life sciences sector.The company's move aims to further expand its influence in the biotechnology industry and explore potential opportunities for synergistic growth.